BChE-IN-51
BChE-IN-51 is a selective, blood-brain barrier-permeable, orally active BChE inhibitor with an IC50 of 0.03 μM against hBChE. BChE-IN-51 reduces ROS production, protects neurons from the toxic effects of hydrogen peroxide and Aβ1-42, and alleviates cognitive impairment. BChE-IN-51 can be used for the research of Alzheimer's disease.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3131794-81-2
- Formel: C26H25FN4O
- Molecular Weight:428.50
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
|
hBCHE 0.03 μM (IC50) |
BChE-IN-51 (Compound W13) (1 nM-100 μM; 5 min) potently and selectively inhibits butyrylcholinesterase (hBChE) with an IC50 of 0.03 μM, and shows extremely low activity against acetylcholinesterase (AChE)[1].
BChE-IN-51 (0-0.125 μM; 4 min) acts as a mixed-type inhibitor of hBChE, with a Ki of 0.57 μM, an α value of 17.3, and a Ki' of 9.9 μM[1].
BChE-IN-51 (1-100 μM; 24 h) exhibits low in vitro cytotoxicity against HT22, BV2 and SH-SY5Y cells, and maintains >90% cell viability at concentrations up to 20 μM after 24 h of incubation[1].
BChE-IN-51 (1-10 μM; 2 h) dose-dependently protects BV2 and SH-SY5Y cells against H2O2-induced damage, with the maximum protective effect observed at 10 μM[1].
BChE-IN-51 (1-10 μM; 2 h) dose-dependently protects SH-SY5Y cells from Aβ1-42-induced damage, and fully restores cell viability at concentrations of 5 and 10 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HT22 mouse hippocampal neuronal cells, BV2 mouse microglial cells, SH-SY5Y human neuroblastoma cells
-
Concentration:1, 5, 10, 20, 50, 100 μM
-
Incubation Time:24 h
-
Result:Maintained cell survival above 90% across all three cell lines at concentrations up to 20 μM.
Induced cytotoxicity only at concentrations ≥50 μM.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Kunming mice (male, 15−18 g, intracerebroventricular injection of Aβ1-42 oligopeptides to induce cognitive impairment)[1]
-
Dosage:10 mg/kg
-
Administration:p.o.; daily; 12 days
-
Result:Significantly shortened the escape latency to the target platform compared to the Aβ1-42 model group.
Reduced the swimming distance to the platform compared to the Aβ1-42 model group.
Restored cognitive function to near normal levels comparable to the positive control tacrine.
Showed no significant effect on mouse body weight during the experimental period.
Chemical Information
-
CAS. Nr. 3131794-81-2
-
Molecular Weight 428.50
-
Formel C26H25FN4O
-
SMILES
FC1=CC=CC=C1C(N/C(NC2=CC=CC=C2CC)=N/CCC3=CNC4=C3C=CC=C4)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Powered by Bioz